Exelixis, Inc.(EXEL.US)成立於1994年，前身為「Exelixis Pharmaceuticals, Inc.」，2000年2月更為現名，總部位於加州南舊金山，為一家生物製藥公司， ... ... <看更多>
「exelixis, inc」的推薦目錄：
exelixis, inc 在 EXEL - Exelixis Inc - 基本資料| 美股| Anue鉅亨 的相關結果
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. ... <看更多>
exelixis, inc 在 Exelixis, Inc. (EXEL) 股價、新聞、報價和過往記錄 - 雅虎財經 的相關結果
EXEL - Exelixis, Inc. ; Beta 值(5 年，每月), 0.72 ; 市盈率(最近12 個月), 57.63 ; 每股盈利(最近12 個月), 0.35 ; 業績公佈日, 2023年5月02日 - 2023年5月08日 ; 遠期股息及 ... ... <看更多>
exelixis, inc 在 Exelixis Inc (EXEL) 財報分析和股票健診，最新股價20.08元 的相關結果
Exelixis Inc (EXEL) 股價和財報分析，最新本益比35.76 倍，現金股利殖利率0.0%。最關鍵的指標和圖表，幫助投資人瞭解EXEL 股票，判斷值不值得投資。 ... <看更多>
exelixis, inc 在 Exelixis | LinkedIn 的相關結果
Exelixis | 41884 followers on LinkedIn. Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients and their ... ... <看更多>
exelixis, inc 在 Exelixis - Wikipedia 的相關結果
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ... ... <看更多>
exelixis, inc 在 搜尋條件Exelixis, Inc. - 台灣藥物臨床試驗資訊網 的相關結果
搜尋條件Exelixis, Inc. ，搜尋結果清單如下，共搜尋到4筆資料：. No. 1 執行狀態：試驗終止 試驗藥品名稱/ 成分： Cabozantinib (XL184) / Cabozantinib ... ... <看更多>
exelixis, inc 在 Exelixis Medical Affairs | Exelixis, Inc 的相關結果
Learn about Exelixis Medical Affairs and how we improve patient outcomes in our clinical trials through innovation, communication, and research. ... <看更多>
exelixis, inc 在 Exelixis, Inc. Company Information - Drugs.com 的相關結果
Exelixis, Inc. manufactures, markets and/or distributes more than 3 drugs in the United States. Medications listed here may also be marketed under different ... ... <看更多>
exelixis, inc 在 Exelixis | EXEL Stock Price, Company Overview & News 的相關結果
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of ... ... <看更多>
exelixis, inc 在 Exelixis Inc（EX9）股价和资讯- Google 财经 的相關結果
获取最新的Exelixis Inc (EX9) 实时报价、过往表现、行情图以及其他财经信息，助您做出更为明智的交易与投资决定。 ... <看更多>
exelixis, inc 在 EXEL | Exelixis Inc股市 - Investing.com 香港 的相關結果
獲得Exelixis Inc股票的詳盡資料，包括價格、圖表、技術分析、歷史數據及Exelixis報告等。 ... <看更多>
exelixis, inc 在 Exelixis Company Profile: Stock Performance & Earnings 的相關結果
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. ... <看更多>
exelixis, inc 在 Exelixis Inc, EXEL:NSQ summary - FT.com - Markets data 的相關結果
Latest Exelixis Inc (EXEL:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. ... <看更多>
exelixis, inc 在 EXEL: Exelixis Inc - Stock Price, Quote and News - CNBC 的相關結果
Get Exelixis Inc (EXEL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ... <看更多>
exelixis, inc 在 Exelixis Inc. - The New York Times 的相關結果
Exelixis Inc. · New Drugs Prove More Effective in Treatment of Kidney Cancer, Studies Find · In Small Test, Experimental Prostate Drug Shows Promise · Glaxo Forms ... ... <看更多>
exelixis, inc 在 EXELIXIS INC. | OpenPayments 的相關結果
EXELIXIS INC. General Payments by Nature of Payment in 2021. ... <看更多>
exelixis, inc 在 Exelixis, Inc. ESG Risk Rating - Sustainalytics 的相關結果
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. ... <看更多>
exelixis, inc 在 Exelixis (@ExelixisInc) / Twitter 的相關結果
Exelixis. @ExelixisInc. Biotechnology company striving to accelerate the development of new medicines for difficult-to-treat cancers. ... <看更多>
exelixis, inc 在 EXEL | Exelixis Inc. Profile - MarketWatch 的相關結果
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat ... ... <看更多>
exelixis, inc 在 Exelixis Inc. Equity | 936718 | US30161Q1040 - Börse Frankfurt 的相關結果
Exelixis Inc. share price in real-time (936718 / US30161Q1040), charts and analyses, news, key data, turnovers, company data. ... <看更多>
exelixis, inc 在 購買Exelixis Inc 股票(EXEL) 並在etoro上查看股價 的相關結果
在eToro上，您可以購買$EXEL 股價或其他股票並支付零傭金！ 關注Exelixis Inc 股價並獲取更多資訊。 條款適用。 ... <看更多>
exelixis, inc 在 Exelixis, Inc主要統計數據和比率– NASDAQ:EXEL - TradingView 的相關結果
獲取Exelixis, Inc財務統計數據和比率。查看EXEL市值、市盈率、EPS、ROI等。 ... <看更多>
exelixis, inc 在 Articles about Exelixis, Inc. - BioSpace 的相關結果
Exelixis, Inc. (Nasdaq: EXEL) today announced initial results from the ongoing dose-escalation stage of QUARTZ-101, a phase 1 clinical trial evaluating XL102, a ... ... <看更多>
exelixis, inc 在 EXELIXIS, INC. 的相關結果
EXELIXIS, INC. Funding Organization. Temporal Graph · Map of Science. Research. Research. Awards Grant. Private Grant · Private Grant · Private Grant ... ... <看更多>
exelixis, inc 在 Exelixis Inc - Company Profile and News - Bloomberg Markets 的相關結果
The Company offers medicines to treat and defeat kidney and thyroid cancer and advanced melanoma. Exelixis develops strategic alliances with pharmaceutical and ... ... <看更多>
exelixis, inc 在 EXELIXIS, INC. : EXEL Stock Price - Market Screener 的相關結果
Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. ... <看更多>
exelixis, inc 在 Exelixis, Inc. Common Stock (EXEL) - Nasdaq 的相關結果
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. ... <看更多>
exelixis, inc 在 EXEL | Exelixis Inc. Stock Price & News - WSJ 的相關結果
View the latest Exelixis Inc. (EXEL) stock price, news, historical charts, analyst ratings and financial information from WSJ. ... <看更多>
exelixis, inc 在 EXEL - Exelixis Inc Stock Price Quote - NASDAQ - Morningstar 的相關結果
See the latest Exelixis Inc stock price (NASDAQ:EXEL), related news, valuation, dividends and more to help you make your investing decisions. ... <看更多>
exelixis, inc 在 Exelixis, Inc. - AnnualReports.com 的相關結果
Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, ... ... <看更多>
exelixis, inc 在 Exelixis, Inc. - Cancer Therapy Advisor 的相關結果
Drugs. CABOMETYX. Bladder, kidney, and other urologic cancers; Colorectal and other GI cancers; Pancreatic, thyroid, and other endocrine cancers. ... <看更多>
exelixis, inc 在 Exelixis - Crunchbase Company Profile & Funding 的相關結果
About. Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases ... ... <看更多>
exelixis, inc 在 Exelixis Inc Share Price Com Stk Usd0.001 的相關結果
The latest Exelixis Inc Com Stk Usd0.001 share price. View recent trades and share price information for Exelixis Inc Com Stk Usd0.001. ... <看更多>
exelixis, inc 在 Exelixis Inc - Manufacturing Chemist 的相關結果
Exelixis Inc. www.exelixis.com. 210 East Grand Avenue PO Box 511. South San Francisco California CA 94080-0511. United States +1 650 837 7000 ... ... <看更多>
exelixis, inc 在 Exelixis Inc Locations - Headquarters & Offices – GlobalData 的相關結果
Exelixis Inc headquarters address, phone number and website information and details on other Exelixis Inc's locations and subsidiaries. ... <看更多>
exelixis, inc 在 exelixis, inc. - GSA eLibrary Contractor Information 的相關結果
EXELIXIS, INC. Address: 1851 HARBOR BAY PKWY ALAMEDA, CA 94502. Phone: 650-837-8155. E-Mail: ... ... <看更多>
exelixis, inc 在 Exelixis (Nasdaq:EXEL) - Stock Price, News & Analysis 的相關結果
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the ... ... <看更多>
exelixis, inc 在 Exelixis, Inc. - MPR - eMPR.com 的相關結果
Drugs. CABOMETYX. Bladder, kidney, and other urologic cancers; Colorectal and other GI cancers; Pancreatic, thyroid, and other endocrine cancers. ... <看更多>
exelixis, inc 在 Exelixis Inc - JUST Capital 的相關結果
Exelixis is a biopharmaceutical company that commercializes new medicines to improve care and outcomes for people with cancer. ... <看更多>
exelixis, inc 在 Exelixis Announces Fourth Quarter and Full Year 2022 ... 的相關結果
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by ... ... <看更多>
exelixis, inc 在 Exelixis Inc Lobbying Profile • OpenSecrets 的相關結果
Client Profile: Exelixis Inc ... A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is ... ... <看更多>
exelixis, inc 在 Exelixis Inc. | BioWorld 的相關結果
-based Exelixis Inc.'s tyrosine kinase inhibitor, Cabometyx (cabozantinib), which targets MET, AXL and VEGF, and PD-1 drug Opdivo (nivolumab) from Bristol Myers ... ... <看更多>
exelixis, inc 在 Exelixis, Inc | Scholars@Duke 的相關結果
Exelixis, Inc. ... Exelixis, Inc. Duke Logo. About · Support · Index · Manage Scholars Data. ©2023 Duke University | Terms of Use | Powered by VIVO. ... <看更多>
exelixis, inc 在 EXELIXIS INC. | Dollars for Docs - ProPublica 的相關結果
Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site. Has Your Doctor Received Drug or Device Company Money? For example ... ... <看更多>
exelixis, inc 在 Exelixis Inc. Company Profile - The Business Journals 的相關結果
Exelixis Inc. Alameda, CA. Overview. Industry: biotechnology; pharmaceuticals; Revenue ... ... <看更多>
exelixis, inc 在 FLASCO / Exelixis, Inc. - Florida Society of Clinical Oncology 的相關結果
Exelixis, Inc. Exelixis. Partner Level: Platinum; Company Headquarters: 210 E Grand Ave San Francisco, CA ... ... <看更多>
exelixis, inc 在 Kinaxis Partners With Exelixis to Advance Supply Chain ... 的相關結果
An oncology-focused biotechnology company headquartered in Alameda, California, Exelixis is on a mission to help cancer patients recover ... ... <看更多>
exelixis, inc 在 EXEL: Exelixis, Inc. - Summary - Jitta 的相關結果
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in ... ... <看更多>
exelixis, inc 在 Exelixis Inc EXEL - Stocks - U.S. News – Money 的相關結果
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat ... ... <看更多>
exelixis, inc 在 EXEL | Exelixis Inc. Stock Overview (U.S.: Nasdaq) - Barron's 的相關結果
Complete Exelixis Inc. stock information by Barron's. View real-time EXEL stock price and news, along with industry-best analysis. ... <看更多>
exelixis, inc 在 Exelixis, Inc. (Nasdaq - STORM Therapeutics 的相關結果
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate ... ... <看更多>
exelixis, inc 在 Exelixis Inc Key Statistics | EXEL | US30161Q1040 | Fidelity 的相關結果
Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. ... <看更多>
exelixis, inc 在 Exelixis and Ryvu Therapeutics Establish Exclusive License ... 的相關結果
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate ... ... <看更多>
exelixis, inc 在 Exelixis: Beyond The Cabozantinib Franchise - Seeking Alpha 的相關結果
Riding its flagship molecule (cabozantinib), Exelixis, Inc. (NASDAQ:EXEL) has made its name in the field of oncology. ... <看更多>
exelixis, inc 在 Price-Forecasting Models for Exelixis, Inc. EXEL Stock ... 的相關結果
Amazon.com: Price-Forecasting Models for Exelixis, Inc. EXEL Stock (NASDAQ Composite Components): 9798673931547: Ta, Ton Viet: Books. ... <看更多>
exelixis, inc 在 Exelixis, Inc | San Francisco, United States | - ResearchGate 的相關結果
Standard endpoints such as objective response rate are usually poorly correlated with overall survival (OS) for treatment with immune checkpoint inhibitors. ... <看更多>
exelixis, inc 在 Working at Exelixis | Glassdoor 的相關結果
Mission: Exelixis is on a Mission to Help Cancer Patients Recover Stronger and Live Longer. ... <看更多>
exelixis, inc 在 Exelixis, Inc. - Alameda, USA - bionity.com 的相關結果
Exelixis Publishes World's Most Comprehensive Collection of Functional Gene Knockouts in a Multicellular Organism. South San Francisco. Scientists at Exelixis, ... ... <看更多>
exelixis, inc 在 Exelixis Headquarters Relocation - XL Construction 的相關結果
XL Construction was tapped by cancer drug developer Exelixis to renovate 137000 s.f. in three ... Exelixis Headquarters Relocation ... Exelixis, Inc. ... <看更多>
exelixis, inc 在 Exelixis Inc (EXEL) | OANDA Trading Platform | Market Rates 的相關結果
Name Exelixis Inc. Currency USD. Symbol EXEL.US. Minimum order value. Ticker EXEL. Trading hours monday-friday 15:30-22:00. Type Stocks US. ... <看更多>
exelixis, inc 在 Exelixis Inc. (EXEL): Share Price, Stock Analysis, Annual Report 的相關結果
Get Exelixis Inc. (EXEL)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. ... <看更多>
exelixis, inc 在 Exelixis, Inc. v. Kappos, Case No. 1:12cv96 - Casetext 的相關結果
Read Exelixis, Inc. v. Kappos, Case No. 1:12cv96, see flags on bad law, and search Casetext's comprehensive legal database. ... <看更多>
exelixis, inc 在 Ipsen and its partner Exelixis receive positive CHMP opinion ... 的相關結果
Exelixis, Inc. ... The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines ... ... <看更多>
exelixis, inc 在 EXELIXIS, INC. Plaintiff, v. MSN LABORATORIES PRIVATE ... 的相關結果
EXELIXIS, INC. Plaintiff, v. MSN LABORATORIES PRIVATE LIMITED and MSN PHARMACEUTICALS INC.,. Case: 19-2017. Judge:. ... <看更多>
exelixis, inc 在 Subsidiaries of Exelixis, Inc, - SEC.gov 的相關結果
Exhibit 21.1. SUBSIDIARIES OF EXELIXIS, INC. Exelixis Plant Sciences, Inc., a Delaware corporation. X-Ceptor Therapeutics, Inc., a Delaware corporation. ... <看更多>
exelixis, inc 在 Exelixis Trademarks, Patents, Litigation Filings and Court ... 的相關結果
Exelixis legal profile including 66 Trademarks, 180 Patent Grants, 169 Patent Applications, 16 Federal Litigation Filings, ... Exelixis, Inc. v. ... <看更多>
exelixis, inc 在 Exelixis, Inc. Company Profile | Alameda, CA - Dun & Bradstreet 的相關結果
Company Description: Exelixis is an oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of ... ... <看更多>
exelixis, inc 在 BRIEF-Exelixis Inc Q1 Earnings Per Share $0.37 | Reuters 的相關結果
May 2 (Reuters) - Exelixis Inc: * EXELIXIS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ... ... <看更多>
exelixis, inc 在 Exelixis與武田簽署在日本進行新型抗癌藥Cabozantinib商品化 ... 的相關結果
Exelixis, Inc.與武田藥品昨天(7日)宣布一份在日本進行cabozantinib商品化和進一步臨床開發的排他性授權協議，cabozantinib是Exelixis的主打抗癌藥。 ... <看更多>
exelixis, inc 在 Exelixis, Inc. - List of Drugs - NDC Labeler/Manufacturer 的相關結果
Exelixis, Inc. - NDC products. NDC labeler, manufacturer of drugs and pharmaceuticals. Products with assigned NDCs are displayed. ... <看更多>
exelixis, inc 在 Exelixis, Inc. 2022 Annual Meeting - Proxydocs.com 的相關結果
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery ... ... <看更多>
exelixis, inc 在 EXEL (Exelixis, Inc.) Stock Price Today & Updates - INDmoney 的相關結果
Founded in 1994, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, ... ... <看更多>
exelixis, inc 在 Exelixis Announces Initiation of Cabozantinib Investigator ... 的相關結果
Exelixis, Inc. is a biotechnology company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its proprietary ... ... <看更多>
exelixis, inc 在 Exelixis' Cabometyx R&D On Track Despite Pivotal Kidney ... 的相關結果
The US biotechs are joining forces to form a new, listed company with sufficient cash to advance EIP's potentially disease-modifying drug ... ... <看更多>
exelixis, inc 在 EXEL Stock Price & Charts | Exelixis - YCharts 的相關結果
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. Its lead molecule, ... ... <看更多>
exelixis, inc 在 Exelixis Company Profile, News, Rankings | Fortune 的相關結果
Fastest Growing Companies 2020-17-Exelixis. Courtesy of Exelixis. Company Information. As of 10/29/20. Country. U.S.. Headquarters. Alameda, Calif. Industry. ... <看更多>
exelixis, inc 在 Exelixis Enters into Exclusive License Agreement with WuXi ... 的相關結果
March 8, 2021 –WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, and Exelixis, Inc. (Nasdaq: EXEL) ... ... <看更多>
exelixis, inc 在 Exelixis, Inc. - Berkeley IPIRA 的相關結果
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery ... ... <看更多>
exelixis, inc 在 天演藥業宣佈與Exelixis 簽訂合作許可協議，共同開發具有更佳 ... 的相關結果
Exelixis, Inc. (Nasdaq: EXEL) 成立於1994 年，是一家新藥產品已經成功商業化及專注於腫瘤學的生物技術公司，致力加速難治性癌症新藥的發現、開發和商業 ... ... <看更多>
exelixis, inc 在 Exelixis Inc. - Company Profiles - BCIQ 的相關結果
Gunjan Ohri, Data Content Analyst Gisela Schwab, CMO and president of product development and medical affairs of Exelixis Inc.. ... <看更多>
exelixis, inc 在 Exelixis and STORM Therapeutics Enter into Exclusive ... 的相關結果
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate ... ... <看更多>
exelixis, inc 在 Exelixis, Inc. | Global Research Projects - UCSF 的相關結果
Exelixis, Inc. ... A. P. Giannini Foundation · ADMA Biologics, Inc. AIDS Support Organization, The · AIDS Walk San Francisco Foundation ... ... <看更多>
exelixis, inc 在 Exelixis (EXEL) Surges 25.4% so Far in 2023: Here's Why 的相關結果
Investors cheered the company's effort to return shareholders' value through this repurchase program. Zacks Investment Research ... <看更多>
exelixis, inc 在 Exelixis Inc (EXEL) Latest News & Price - InvestorPlace 的相關結果
Check out our EXEL stock analysis, current EXEL quote, charts, and historical prices for Exelixis Inc stock. ... <看更多>
exelixis, inc 在 抗癌药公司：伊克力西斯Exelixis(EXEL) - 美股之家 的相關結果
伊克力西斯Exelixis, Inc.(NASDAQ:EXEL)创立于1994年，前身是Exelixis Pharmaceuticals, Inc.，于2000年2月改为现用名，总部位于美国加州南旧金山， ... ... <看更多>
exelixis, inc 在 Four Early-Career Cancer Researchers Earn Prestigious ... 的相關結果
This year's awards were made possible through support from AbbVie; Amgen, Inc.; Exelixis, Inc., and Pfizer, Inc. ... <看更多>
exelixis, inc 在 Exelixis, Inc.: A Promising Player in Oncology Medicine 的相關結果
In the ever-evolving world of biotechnology, Exelixis, Inc. stands out as a leading oncology company focusing on discovering, developing, ... ... <看更多>
exelixis, inc 在 Exelixis, Inc. (NASDAQ:EXEL) Shares Purchased by ... 的相關結果
Exelixis, Inc operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to ... ... <看更多>
exelixis, inc 在 Datadog Stock Price Prediction. 07 billion and $2. 55 ... 的相關結果
On average, sell-side analysts forecast that Datadog, Inc. (NASDAQ:DDOG) floating ... 12-month price forecasts for Exelixis Inc have a median target of 25. ... <看更多>
exelixis, inc 在 Biotechnology: Concepts, Methodologies, Tools, and ... 的相關結果
Inc. Regeneron Exelixis Inc. Pharma. ... Zealand Pharma A/S Isis Pharmaceuticals Ascenta Therapeutics Regeneron Pharma Exelixis Inc. Merrimack Pharma. ... <看更多>
exelixis, inc 在 Exelead Stock - Schwebebad 的相關結果
EXEL Exelixis Inc — Stock Price and Discussion | Stocktwits. Founded in 2017, the company specializes in manufacturing lipid nanoparticle, liposome, ... ... <看更多>
exelixis, inc 在 Four early-career cancer researchers earn pre | EurekAlert! 的相關結果
This year's awards were made possible through support from AbbVie; Amgen, Inc.; Exelixis, Inc., and Pfizer, Inc. ... <看更多>
exelixis, inc 在 STELLAR Clinical Trials (Exelixis) | HCP Website 的相關結果
Exelixis is dedicated to identifying, discussing, and implementing solutions that will increase the number of patients from underrepresented populations in all ... ... <看更多>
exelixis, inc 在 Exelixis - Helping Patients Recover Stronger and Live Longer 的相關結果
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause. ... <看更多>